
Shares of Novo Nordisk A/S (NYSE:NVO) are trading lower Wednesday morning, extending a dramatic sell-off from Tuesday’s session. Here’s what investors need to know.
What To Know: The downward momentum follows Tuesday’s announcement where the Danish pharmaceutical giant slashed its 2025 financial outlook for the second time this year, sending its stock plummeting by as much as 25%.